Onder, F. C. Et Al. 2021. Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo. ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE , vol.4, no.2 , 926-940.

Onder, F. C., Kahraman, N., Atici, E. B., Cagir, A., Kandemir, H., Tatar, G., ... Tok, T. T.(2021). Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo. ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE , vol.4, no.2, 926-940.

Onder, Ferah Et Al. "Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo," ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE , vol.4, no.2, 926-940, 2021

Onder, Ferah C. Et Al. "Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo." ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE , vol.4, no.2, pp.926-940, 2021

Onder, F. C. Et Al. (2021) . "Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo." ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE , vol.4, no.2, pp.926-940.

@article{article, author={Ferah Comert Onder Et Al. }, title={Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo}, journal={ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE}, year=2021, pages={926-940} }